Literature DB >> 19867184

STUDIES ON IMMUNE HUMAN HEMOLYSIS : II. THE DONATH-LANDSTEINER REACTION AS A MODEL SYSTEM FOR STUDYING THE MECHANISM OF ACTION OF COMPLEMENT AND THE ROLE OF C'1 AND C'1 ESTERASE.

C F Hinz1, M E Picken, I H Lepow.   

Abstract

1. The inactivation, of C'1 blocks the completion of the cold phase of the Donath-Landsteiner reaction; inactivation of the other components of complement does not interfere with the cold phase of the reaction. 2. C'2, C'3, and C'4 are required for the completion of the hemolytic reaction. C'4 reacts in either the cold or warm phase, but C'2 and C'3 must react in the warm phase. 3. Partially purified C'1 or C'1 esterase can be substituted for whole serum in the cold phase, although neither reagent contains any of the other components of complement 4. Partially purified serum inhibitor of C'1 esterase blocks the effect of C'1 esterase in the cold phase, and reverses the effect of complement, C'1 or C'1 esterase when incubated with "activated" cells after the cold phase. 5. C'1 esterase activity can be eluted from "activated" erythrocytes with Na(3)EDTA. 6. The components of human complement in this human hemolytic reaction act in the order C'1, C'4, C'2, C'3. Ca(++) is required for the reaction with C'1, and Mg(++) is required for the reaction with C'2. 7. Accordingly, a functional role of C'1 esterase in a human disease state is demonstrated, and a human model is established for the study of the mechanism of action of complement.

Entities:  

Year:  1961        PMID: 19867184      PMCID: PMC2137331          DOI: 10.1084/jem.113.1.193

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Measurement of the components of complement by the reagent titration technique.

Authors:  R J WEDGWOOD
Journal:  Z Immun exp ther       Date:  1959 Oct-Nov

2.  Concerning the mechanism of complement action. V. The early steps in immune hemolysis.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1960-03       Impact factor: 5.422

3.  Assay and properties of serum inhibitor of C'l-esterase.

Authors:  L R LEVY; I H LEPOW
Journal:  Proc Soc Exp Biol Med       Date:  1959 Aug-Sep

4.  Kinetics of human complement. II. Separation of the reaction between human complement and sensitized cells into two steps.

Authors:  M A LEON
Journal:  J Immunol       Date:  1956-06       Impact factor: 5.422

5.  Elution of an esterase from antigen-antibody aggregates treated with human complement.

Authors:  I H LEPOW; O D RATNOFF; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

6.  Observations on a pro-esterase associated with partially purified first component of human complement (C'1).

Authors:  I H LEPOW; O D RATNOFF; F S ROSEN; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

7.  THE ROLE OF THE COMPONENTS OF COMPLEMENT IN SPECIFIC IMMUNE FIXATION.

Authors:  L Pillemer; S Seifter; E E Ecker
Journal:  J Exp Med       Date:  1942-04-01       Impact factor: 14.307

8.  Studies on immune cellular injury. I. Cytotoxic effects of antibody and complement.

Authors:  A ROSS; I H LEPOW
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

9.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

10.  Studies on immune cellular injury. II. Functional role of C'1 esterase in immune cytotoxicity.

Authors:  I H LEPOW; A ROSS
Journal:  J Exp Med       Date:  1960-12-01       Impact factor: 14.307

View more
  3 in total

1.  [C'1-esterase and C'1-esterase inhibitor in the serum of patients with hereditary genuine Quincke's edema].

Authors:  U Gottstein; D J Yoo; H Büttner
Journal:  Klin Wochenschr       Date:  1967-03-01

2.  COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE.

Authors:  O D RATNOFF; I H LEPOW
Journal:  J Exp Med       Date:  1963-11-01       Impact factor: 14.307

3.  Chromatographic resolution of the first component of human complement into three activities.

Authors:  I H LEPOW; G B NAFF; E W TODD; J PENSKY; C F HINZ
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.